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Controlled trial of chiorambucil and azathioprine in idiopathic
chronic glomerulonephritis (G.N.). G. Lagrue, D. Bernard, J.
Bariety, P. Druet and J. Guenel. Centre de Recherches sur les
Néphropathies (INSERM-Association Claude Bernard), Hbpital
Henri Mondor, Creteil, France, 107 adult patients with idiopathic
chronic G.N., with normal renal function and blood pressure,
were treated with chiorambucil, azathioprine or placebo during a
one-year contfolled prospective study. They were histologically
defined as membranous G.N. with subepithelial deposits (M.G.N.,
41 cases), IgA deposits mesangial G.N. (IgA G.N., 23 cases) and
membranoproliferative G.N. (M.P.G.N., 43 cases). By random as-
signment 33 patients received placebo, 37 received chlorambucil
(0.2 mg/kg/day for 6 months, then 0.1 mg/kg/day) and 37
received azathioprine (3 mg/kg/day for 6 months, then 2 mg/kg/
day). Results were assessed according to the daily variations of
proteinuria and classified as: I) complete remission (C.R.): disap-
pearance of proteinuria; 2) partial remission (P.R.): 50% reduction
of proteinuria, 3) failure (F.). In IgA G.N. and in M.P.G.N.,
no difference was observed among the three groups. In M.G.N.,
however, the results obtained with chlorambucil were significantly
different from those obtained with placebo or azathioprine. Before
treatment, proteinuria levels were comparable in the three groups.
After one year of treatment, the mean level of proteinuria was
significantly reduced in the group treated with chiorambucil. After
one additional year of observation without treatment, complete
remission was obtained in 9 patients in this group. Finally, after a
two-year follow-up (i.e., one year after the end of treatment), our
results could be estimated as follows:
The slow and delayed disappearance of proteinuria in 9 patients
was similar to that observed in toxic M.G.N. (Au, Hg, penicil-
lamine) after cessation of drug contact. We did not perform con-
trol renal biopsies, since in M.G.N. glomerular lesions may persist
for a long time after the disappearance of proteinuria: an
histological improvement may indeed be observed, but only several
years later, as seen in toxic M.G.N. and in earlier personal obser-
vations of chlorambucil-treated M.G.N. which are not included in
this study. Azathioprine frequently induced side effects, requiring
the interruption of treatment in 8 cases out of 37 (among these,
severe leukopenia and anemia occurred in 5 cases). With chioram-
bucil, mild leukopenia was frequently noticed, but without severe
reactions: drug doses were adapted to maintain leucocyte count at
approximately 3000/zl. Treatment had to be stopped in 4 cases out
of 37. After the end of treatment malignancies occurred in 3
patients: 1 skin cancer (with favorable outcome), I gastric cancer
and 1 acute leukemia (with deaths). We therefore concluded that
chlorambucil and azathioprine are completely ineffective in IgA
G.N. and in M.P.G.N. and that M.G.N. is not affected by
azathioprine treatment. In contrast, a one-year chlorambucil treat-
ment has a favorable effect on proteinuria and on the immediate
course of M.G.N. Long-term effects are still unknown, however,
and the favorable effect is severly challenged by life hazards of
drug-induced malignancies.
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Bacterial endotoxins and lupus nephritis. Gilbert J. Fourniè, Paul
H. Lambert and Jean J. Conte. Laboratoire d'Immunopathologie
Rbnale, Centre d'Hêmodialyse Pêriodique, C. H.R. Purpan,
Toulouse; and WHO. Immunopathology Research Unit, Hôpital
Cantonal, Geneve. The injections of bacterial endotoxins or
lipopolysaccharides (LPS) induce in various strains of mice first a
release of deoxyribonucleic acid (DNA) in circulating blood, and
secondly, an induction of anti-DNA antibodies. The anti-DNA
response varies quantitatively according to the strain of the in-
jected mice. It is dose dependent and it is not correlated to the H-2
locus of histocompatibility. In mice developping a high anti-DNA
response, anti-doublestranded and anti-singlestranded DNA an-
tibodies were induced, while low responder mice produce only
anti-singlestranded DNA antibodies. The release of DNA in cir-
culating blood induced by the injection of LPS may be implicated
in the development of this anti-DNA response. The Lipid A frac-
tion which appears to be the active part of the LPS molecule for
this particular effect is also able to induce the release of DNA in
circulating blood. Therefore, the anti-DNA response induced by
LPS may be the result of a release of DNA in a particularly im-
munogenic form at a time when the immune system is
simultaneously stimulated by LPS. These effects of LPS may be im-
plicated in the production of anti-DNA antibodies in patients with
systemic lupus erythematosus during bacterial infections. Similar
mechanisms involving substances which like bacterial lipopolysac-
charides exert a potent mitogenic effect on B cells and
simultaneously induce a release of DNA in extracellular fluids
may trigger the development of a lupus type immune complex
nephritis.
Influence of a different chronic dietary sodium intake on the dis-
tribution of the renal cortical blood flow. N. Lameire and S. Ringoir.
Nephrological Division, Department of Medicine, University
Hospital, De Pintelaan, Ghent, Belgium. It has been postulated
that the distribution of the intrarenal blood flow might play a role
in the regulation of the urinary sodium excretion. However, con-
flicting results on the distribution of renal blood flow and of the
single nephron filtration rate after both acute and chronic different
dietary salt intake have been published. In 20 Sprague-Dawley rats
we restudied the problem using the radioactive microsphere
method for the determination of the intracortical glomerular blood
flow distribution. Group A (N = 12) received a normal salt intake
during 3 weeks; in Group B (N = 8) the tapwater was replaced by a
NaCI 1% solution during 3 weeks and Group C (N = 10) received a
saltless diet during the same time. The animals were anesthetized
with Nembutal the day of the experiment. Using the microsphere
method, the cardiac output (CO), blood pressure (BP), total renal
blood flow (RBF) and the outer (OCF) and inner cortical perfusion
rates (ICF) were measured. A distribution index (DI = OCF/ICF)
was calculated. Although RBF was higher in the B group and
lower in the C group than in the A group no significant difference
in the 3 DI was noted. Therefore, these experiments do not support
the hypothesis that redistribution of the intracortical blood flow








Short-term heparin trial in idiopathic rapidly progressive
glomerulonephritis. J. M. Sue, J. Conte, M. Mignon-Conte, C.
Orfila, D. Durant and H. Ton That. C.H. U. Purpan, Toulouse. 14
cases of idiopathic rapidly progressive glomerulonephritis(I.R.P.G.N.) treated by heparin between 1968 and 1974 were
studied by the authors. Range of extracapillary crescents (E.C.C.)
was 75 to 100% in ten patients, 50 to 75% in four. Gross
protein uria, hematuria and renal failure were always present. Nine
patients were admitted with primary oligo-anuric renal failure.
Eleven patients were treated by repeated hemodialysis before and
during anticoagulant treatment. Heparin was given by i.v. injection
every 3 hr during one to two months with Howell time range from
150 to 200% of control. Heparin was the only treatment in 6 cases,
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associated with dipyridamole in 4, in 3 with prednisone, in 1 with
azathioprine. Five severe or fatal haemorragic complications were
observed. General evolutive pattern was unfavorable: 5 early
deaths, 3 provisional steady-states with 2 late deaths, 6 patients
treated by periodic hemodialysis. Iterative kidney biopsies were
performed in 8 patients. Findings suggest heparin effects mainly on
E.C.C. and fibrinoid deposits but not on glomerular sclerosis. Pres-
ent inefficiency of all treatments in primary oligo-anuric IRGN is
stressed. In patients with better initial GFR, choice between an-
ticoagulant and/or immuno-depressive drugs is to be scrutinized in
individual cases versus potential iatrogenic complications. In
equivocal cases patients will be referred to a chronic hemodialysis
and/or transplantation program.
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